Recently, we demonstrated the ability of a single-chain antibody against the RRM1 domain of TDP43 to target and reduce cytoplasmic mislocalization/aggregation of TDP43 and to improve motor and cognitive performances in an ALS/FTLD mouse models (22). The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.